Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,629 | 36,449 | 26,362 | 46,540 | 58,865 |
| Marketable Securities | 48,641 | 64,899 | 86,166 | 54,040 | 118,569 |
| Receivables | 5,245 | 3,406 | 2,746 | 2,822 | 4,557 |
| Inventories | 10,955 | 11,335 | 10,050 | 9,592 | 15,517 |
| TOTAL | $110,541 | $117,760 | $126,459 | $115,000 | $199,601 |
| Non-Current Assets | |||||
| PPE Net | 8,548 | 6,601 | 9,236 | 14,329 | 18,398 |
| Other Non-Current Assets | 12,018 | 29 | 490 | 354 | 317 |
| TOTAL | $20,566 | $6,630 | $9,726 | $14,683 | $18,715 |
| Total Assets | $131,107 | $124,390 | $136,185 | $129,683 | $218,316 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,749 | 5,608 | 1,717 | 2,988 | 4,742 |
| Accrued Expenses | 15,551 | 11,441 | 7,905 | 8,204 | 10,258 |
| Other current liabilities | 241 | 1,534 | 2,102 | 173 | 140 |
| TOTAL | $38,178 | $31,489 | $22,555 | $14,743 | $19,376 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,948 | 13,991 | 13,347 | N/A | 3,075 |
| Deferred Revenues | 17,637 | 12,906 | 10,831 | 3,378 | 4,236 |
| Other Non-Current Liabilities | 1,986 | 3,097 | 4,066 | 4,758 | 2,786 |
| TOTAL | $19,389 | $37,952 | $44,450 | $5,558 | $7,477 |
| Total Liabilities | $57,567 | $69,441 | $67,005 | $20,301 | $26,853 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,731 | 74,516 | 70,459 | 57,497 | 55,064 |
| Common Shares | 80 | 74 | 66 | 56 | 632,961 |
| Retained earnings | -713,169 | -681,473 | -615,313 | -536,020 | -441,555 |
| Other shareholders' equity | -7 | 9 | 14 | 30 | 57 |
| TOTAL | $73,540 | $54,949 | $69,180 | $109,382 | $191,463 |
| Total Liabilities And Equity | $131,107 | $124,390 | $136,185 | $129,683 | $218,316 |